RM
RVAC Medicines utilizes an mRNA platform to develop novel therapeutics targeting various diseases, enhancing the precision of treatment delivery. The company aims to improve patient outcomes by addressing the limitations of traditional therapies through its innovative mRNA technology.
Updated 2 months ago
Funding
$140M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CB
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- RVAC Medicines utilizes an mRNA platform to develop novel therapeutics targeting various diseases, enhancing the precision of treatment delivery. The company aims to improve patient outcomes by addressing the limitations of traditional therapies through its innovative mRNA technology.